Search Results 91-100 of 10432 for Heart failure with preserved ejection fraction

  1. Cardiovascular Medicine - Clinical trials

    A Study To Evaluate Endovascular Ablation Of The Right Greater Splanchnic Nerve In Subjects Having Heart Failure With Preserved Ejection Fraction. Rochester ...

  2. Barry A. Borlaug, M.D. - Doctors and Medical Staff - Mayo Clinic

    Heart failure with preserved ejection fraction (HFpEF). Pulmonary hypertension. Valvular heart disease. Pericardial disease. Complex cardiovascular conditions ...

  3. Cardiac rehabilitation - Care at Mayo Clinic

    Related · Heart failure with preserved ejection fraction (HFpEF) · Heart failure with reduced ejection fraction (HFrEF) · Spontaneous coronary artery dissection ( ...

  4. Dapagliflozin (DAPA) Effects In HFpEF - Mayo Clinic

    ... heart failure/preserved ejection fraction (HFpEF) and improve cardiac metabolism. Participation eligibility. Participant eligibility includes age, gender ...

  5. Cardiovascular Medicine - Clinical trials

    ... Heart Failure With Preserved Ejection Fraction. Rochester, Minn. The ... heart failure with preserved ejection fraction (HFpEF). A Study To Develop A ...

  6. Nov. 18, 2013 Traci Klein 507-990-1182 (In Dallas) 507-284-5005 (days) 507-284-2511 (evenings) Email: newsbureau@mayo.edu Mayo C

    For example, some patients have preserved ejection fraction, where the heart's lower chambers are stiff and cannot relax enough to fill fully between beats, and.

  7. Publications - Omar F. Abou Ezzeddine, M.D., M.S. - Mayo Clinic

    Application of a transthyretin amyloid cardiomyopathy score to heart failure with mildly reduced or preserved ejection fraction. Eur J Heart Fail. 2025 Dec ...

  8. Diet, Vascular Health and the Gut Microbiome in Heart Failure - Mayo Clinic

    About this study. Heart failure with reduced ejection (HFrEF) is a major health concern. HFrEF is associated with significant endothelial dysfunction (ED).

  9. Spotlight on early detection of 3 heart diseases using ECG-AI - Mayo Clinic News Network

    Left untreated, low ejection fraction can progress to worsening heart failure, affecting quality of life and potentially become severe enough to require a ...

  10. A Study To Test Whether Vicadrostat (BI 690517) In Combination With Empagliflozin Helps People With Heart Failure And A Weak Pumping Function Of The Left Side Of The Heart - Mayo Clinic

    This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join ...